Integrated Diagnostics HoldingsLSE:IDHC +0.40%58 Operating Margin % is 22.09% as of Mar. 2026, which is 39% below its 10-year median of 35.98. GuruFocus rates LSE:IDHC with a GF Score™ of 58/100 and a GF Value™ of $0.57 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Integrated Diagnostics Holdings ranks better than 91.18% on this metric.
Integrated Diagnostics Holdings PLC operating margin has been in a 5-year decline. The average rate of decline per year is -11.3%.
The historical rank and industry rank for Integrated Diagnostics Holdings's Operating Margin % or its related term are showing as below:
LSE:IDHC'
s Operating Margin % Range Over the Past 10 Years
Min: 19.17 Med: 35.98 Max: 43.77
Current: 22.09
LSE:IDHC's Operating Margin % is ranked better than 91.18% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195
vs LSE:IDHC: 22.09
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Integrated Diagnostics Holdings Operating Margin % Related Terms
Integrated Diagnostics Holdings Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:IDHC vs TMO, DHR, IDXX: Operating Margin % Comparison
For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Diagnostics Holdings Operating Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Integrated Diagnostics Holdings's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Diagnostics Holdings (LSE:IDHC) has a Operating Margin % of 22.09% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Integrated Diagnostics Holdings and its competitors. This is 39% below median its historical median of 35.98. Over the past decade, Integrated Diagnostics Holdings' Operating Margin % has ranged from 19.17 to 43.77. According to the industry distribution chart, Integrated Diagnostics Holdings ranks #18 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 8.8%.
Is Integrated Diagnostics Holdings' Operating Margin % too high?
Integrated Diagnostics Holdings' current Operating Margin % of 22.09% is 39% below median its 10-year median of 35.98. Over the past 10 years, this metric has ranged from a low of 19.17 to a high of 43.77. Based on the distribution chart, Integrated Diagnostics Holdings ranks #18 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Integrated Diagnostics Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integrated Diagnostics Holdings' Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integrated Diagnostics Holdings ranks #18 out of 204 companies for Operating Margin %. This places Integrated Diagnostics Holdings in the top 9% of its industry — outperforming the majority of peers. Historically, Integrated Diagnostics Holdings' own Operating Margin % has ranged from 19.17 to 43.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Integrated Diagnostics Holdings and its competitors. Integrated Diagnostics Holdings's current Operating Margin % is 22.09%, which is 39% below median its own 10-year median of 35.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings (LSE:IDHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.57, compared to a current price of $0.50 — trading 11.9% below its estimated fair value. The current Operating Margin % is 22.09%, which is 39% below median its 10-year median of 35.98. Integrated Diagnostics Holdings' overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Integrated Diagnostics Holdings (LSE:IDHC), the current Operating Margin % is 22.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued.
The current stock price of $0.50 is trading 11.9% below its estimated GF Value™ of $0.57.
GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.
Key valuation signals for LSE:IDHC:
Operating Margin %: 22.09% (39% below median its 10-year median of 35.98)
GF Value™: $0.57 vs. price of $0.50 (11.9% below fair value)
No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Diagnostics Holdings Business Description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
58GF Score
Get the complete analysis for LSE:IDHC
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IDHC has been successfully added to your 
